Immunoglobulin Free Light Chain
Immunoglobulins are the major constituent of the humoral immunity and are produced by terminally differentiated B-lymphocytes (plasma cells). Structurally, immunoglobulins are composed of a pair of heavy chains and a pair of light chains. Light chains are combined with the heavy chain by a disulfide bond at the hinge region. Two types of light chains are produced, termed kappa (κ) and lambda (λ). A single plasma cell will only produce one light chain type and in a normal polyclonal immunoglobulin response kappa and lambda light chains are produced in a 0.26-1.65 κ: λ ratio. In normal individuals, the levels of free light chains (FLC) are low. However, in clonal plasma cell neoplasms, there is uncontrolled production of monoclonal immunoglobulin molecules (intact immunoglobulins, heavy chains only, light chains only, a combination of these) and there is often the release of monoclonal free light chains in the blood. Quantitation of these free light chains and finding an abnormal serum FLC κ: λ ratio can provide evidence of monoclonal production and aid in the diagnosis of neoplastic plasma cell disorders.
Excessive amounts of FLCs in circulation are filtered by the kidney in amounts that exceed the renal tubular absorption and therefore FLCs appear in urine (previously termed Bence Jones proteins). The normal κ: λ ratio in urine is 0.7-6.2 and an abnormal ratio is suggestive of a clonal or oligoclonal population of plasma cells. Free light chains in urine can also be increased in patients with renal disorders, however, unless there is a clonal plasma cell disorder the κ: λ ratio of the uirne light chains maintains the normal 0.7-6.2 ratio.
- As an aid in the diagnosis of multiple myeloma and other plasma cell dyscrasias
- Useful in monitoring the treatment of malignant disorders of plasma cells
- Aids in the diagnosis and classification of amyloidosis
Increased in:
- Multiple myeloma
- Monoclonal gammopathies
- Amyloidosis
- Waldenstrom macroglobulinemia
- Plasma cell neoplasms
Decreased in:
- Hypogammaglobulinemia
- Agammaglobulinemia
- Liver diseases
- Aplastic anemia
- Vitamin B12 deficiency
| Serum | Reference Range |
| Free κ light chains | 3.3−19.4 mg/L |
| Free λ light chains | 5.7−26.3 mg/L |
| κ:λ free light chain ratio | 0.26−1.65 |
| Urine | Reference Range |
| Total κ light chains | <0.9 mg/dL |
| Total λ light chains | <0.7 mg/dL |
| κ:λ free light chain ratio | 0.7-6.2 |
| CSF | Reference Range |
| Free κ light chains | <1.00 mg/L |
Serum (SST or Red-top tube), urine and Cerebrospinal fluid.
Stability Serum
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: 28 days
Stability Urine
- Ambient: 72 hrs.
- Refrigerated (preferred): 21 days
- Frozen: 21 days
Cerebrospinal fluid (CSF)
- Stability CSF
- Ambient: 24 hrs.
- Refrigerated (preferred): 72 hrs.
- Frozen: 28 days
- Blood. 2016; 12:2599-2606 [PMID: 27737890]
- Scand J Clin Lab Invest Suppl. 2016; 113-8 [PMID: 27467897]
- JAMA. 1992; 11:2946-51 [PMID: 1433713]
- N Engl J Med. 2021; 5:1931-1941 [PMID: 34010532]
- Am J Hematol. 2020; 7:848-860 [PMID: 32267020]